Shanghai Bio-heart Statements
21
Data from Shanghai Bio-heart`s earning releases including common size income statement and balance sheet.
Common size analysis evaluates financial statements by expressing each line item as a percentage of a base amount for that period.
Key Information:
Report currency:
CNY - Chinese yuan
Last reporting period:
30 Jun, 2023
Next reporting period:
27 Dec, 2023
Report frequency:
Semi-annual
Earnings release date:
—
Expected release date:
—
Shanghai Bio-heart Income Statement
B
M
CNY (except Earnings per share)
Financial
Revenue
Cost of sales
Gross profit
Research and development
Selling, general and administrative
Total operating expenses
Operating income
Interest expense
Other income
Income before tax
Provision for income taxes
Net income
Diluted earnings per share
Shares outstanding after dilution
—
—
100
—
0
—
—
0
68.497
0
30.908
0
98.872
-21.8 %
0
-98.872
21.8 %
0
3.755
0
—
0
-95.117
17.5 %
0
—
0
-86.186
16.2 %
0
-0.353
243.94
—
—
100
—
0
—
—
0
86.439
0
40.517
0
126.51
1.5 %
0
-126.51
-1.5 %
0
11.222
0
—
0
-115.29
0.2 %
0
—
0
-102.8
-1.3 %
0
-0.422
243.55
—
—
100
—
0
—
—
0
71.391
0
53.853
0
124.65
-30.2 %
0
-124.65
30.2 %
0
9.075
0
—
0
-115.58
36.6 %
0
—
0
-101.44
37.3 %
0
-0.416
243.94
—
—
100
—
0
—
—
0
93.742
0
90.889
0
178.62
-20.6 %
0
-178.62
20.6 %
0
-3.7
0
—
0
-182.31
19.9 %
0
—
0
-161.66
19.1 %
0
-0.795
203.24
—
—
100
—
0
—
—
0
120.49
0
104.53
0
224.88
—
0
-224.88
—
0
-2.626
0
—
0
-227.51
—
0
—
0
-199.79
—
0
-0.84
237.94